Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3807 | 636 | 25.3 | 41% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
595 | 12268 | BERBERINE//AMARYLLIDACEAE ALKALOIDS//SANGUINARINE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
22425 | 325 | NEFOPAM//ORPHENADRINE//ANALGESICS NON OPIOID NEFOPAM |
31686 | 119 | AGONIST ANTAGONIST DISCRIMINATION//BINDING THERMODYNAMICS//W SSM RATS |
34361 | 73 | |
34544 | 68 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
35143 | 51 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y//TARGET BASED DRUG |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEFOPAM | Author keyword | 43 | 62% | 7% | 44 |
2 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | Address | 11 | 69% | 1% | 9 |
3 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | Address | 7 | 57% | 1% | 8 |
4 | ORPHENADRINE | Author keyword | 6 | 40% | 2% | 12 |
5 | TARGET BASED DRUG | Author keyword | 4 | 75% | 0% | 3 |
6 | ANALGESICS NON OPIOID NEFOPAM | Author keyword | 3 | 100% | 0% | 3 |
7 | AGONIST ANTAGONIST DISCRIMINATION | Author keyword | 3 | 60% | 0% | 3 |
8 | RESISTANCE MODIFYING AGENT | Author keyword | 2 | 50% | 0% | 3 |
9 | ABDOMINAL WRITHING | Author keyword | 1 | 50% | 0% | 2 |
10 | DESMETHYL NEFOPAM | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEFOPAM | 43 | 62% | 7% | 44 | Search NEFOPAM | Search NEFOPAM |
2 | ORPHENADRINE | 6 | 40% | 2% | 12 | Search ORPHENADRINE | Search ORPHENADRINE |
3 | TARGET BASED DRUG | 4 | 75% | 0% | 3 | Search TARGET+BASED+DRUG | Search TARGET+BASED+DRUG |
4 | ANALGESICS NON OPIOID NEFOPAM | 3 | 100% | 0% | 3 | Search ANALGESICS+NON+OPIOID++NEFOPAM | Search ANALGESICS+NON+OPIOID++NEFOPAM |
5 | AGONIST ANTAGONIST DISCRIMINATION | 3 | 60% | 0% | 3 | Search AGONIST+ANTAGONIST+DISCRIMINATION | Search AGONIST+ANTAGONIST+DISCRIMINATION |
6 | RESISTANCE MODIFYING AGENT | 2 | 50% | 0% | 3 | Search RESISTANCE+MODIFYING+AGENT | Search RESISTANCE+MODIFYING+AGENT |
7 | ABDOMINAL WRITHING | 1 | 50% | 0% | 2 | Search ABDOMINAL+WRITHING | Search ABDOMINAL+WRITHING |
8 | DESMETHYL NEFOPAM | 1 | 100% | 0% | 2 | Search DESMETHYL+NEFOPAM | Search DESMETHYL+NEFOPAM |
9 | NEFOPAM HYDROCHLORIDE | 1 | 50% | 0% | 2 | Search NEFOPAM+HYDROCHLORIDE | Search NEFOPAM+HYDROCHLORIDE |
10 | CULTURED CEREBELLAR NEURONS | 1 | 33% | 0% | 3 | Search CULTURED+CEREBELLAR+NEURONS | Search CULTURED+CEREBELLAR+NEURONS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEFOPAM HYDROCHLORIDE | 11 | 69% | 1% | 9 |
2 | BENZOXAZOCINE ANALGESIC DRUG | 6 | 80% | 1% | 4 |
3 | SOLID STATE STEREOCHEMISTRY | 6 | 80% | 1% | 4 |
4 | COPPER CHELATE | 4 | 75% | 0% | 3 |
5 | NAPROXEN METABOLISM | 3 | 100% | 0% | 3 |
6 | 2 3 5 6 TETRAMETHYLBENZOQUINONE | 2 | 67% | 0% | 2 |
7 | DRIVEN BINDING | 2 | 67% | 0% | 2 |
8 | NEFOPAM | 2 | 24% | 1% | 7 |
9 | FUNDAMENTAL DIFFERENCE | 2 | 26% | 1% | 6 |
10 | ORPHENADRINE | 2 | 21% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nefopam for the prevention of postoperative pain: quantitative systematic review | 2008 | 30 | 19 | 68% |
THERMODYNAMIC ANALYSIS OF THE DRUG-RECEPTOR INTERACTION | 1989 | 45 | 36 | 31% |
Translational study in cancer research | 2002 | 3 | 2 | 100% |
(Extra)thermodynamics of the drug-receptor interaction | 1999 | 15 | 10 | 60% |
Efficacy and Safety of Neuromodulators in Inflammatory Arthritis: A Cochrane Systematic Review | 2012 | 2 | 19 | 37% |
Receptor binding thermodynamics at the neuronal nicotinic receptor | 2004 | 14 | 21 | 38% |
Solution- and solid-state NMR studies of eight- and nine-membered medium ring cis-cycloalkene stereochemistry | 2005 | 1 | 28 | 61% |
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer | 2014 | 3 | 127 | 10% |
Neuromodulators for pain management in rheumatoid arthritis | 2012 | 2 | 43 | 16% |
Single dose oral nefopam for acute postoperative pain in adults | 2009 | 1 | 28 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | 11 | 69% | 1.4% | 9 |
2 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | 7 | 57% | 1.3% | 8 |
3 | BIOCODEX | 1 | 30% | 0.5% | 3 |
4 | ANESTHESIOL INTENS CARE 2 | 1 | 19% | 0.8% | 5 |
5 | ENVIRONM CARCINOGENESIS TOXICOL | 1 | 16% | 0.8% | 5 |
6 | EDS SERV | 1 | 50% | 0.2% | 1 |
7 | HLTH LAW SCI POLICY | 1 | 50% | 0.2% | 1 |
8 | INTENS CARE ANAESTHESIOL DAR | 1 | 50% | 0.2% | 1 |
9 | SERV PROF GERARD JANVIER | 1 | 50% | 0.2% | 1 |
10 | HOSP UNIT | 1 | 17% | 0.5% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000011203 | 3 IMIDAZOLINE 3 OXIDE//3 IMIDAZOLINE//3 IMIDAZOLINE 3 OXIDES |
2 | 0.0000010633 | MELOTHRIA MADERASPATANA//OSBECKIA ASPERA//PHOTOLYSIS OF H2O2 |
3 | 0.0000009887 | HYPERALGESIA//NEUROPATHIC PAIN//ANTINOCICEPTION |
4 | 0.0000009731 | MANGANESEIII ACETATE//BALANOL//BETA KETO ENOL ETHERS |
5 | 0.0000007903 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
6 | 0.0000007556 | HBEREICH CHEM ANORGAN CHEM//METHYLENE LACTONES//HYDROIODINATION |
7 | 0.0000007538 | STRUCT ORGAN ANAL//AZANION//AB INITIO FORCE FIELD |
8 | 0.0000007118 | DT DIAPHORASE//EO9//NQO1 |
9 | 0.0000006978 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
10 | 0.0000006134 | GRAPTOPETALUM PARAGUAYENSE E WALTHER//AGR CHEM CHIKUSA KU//AGR CHEM NUTR BIOCHEM |